Skip to main content

Articles

FDA Approvals, In the News
Tazverik Receives FDA Approval as First Treatment Specifically for Metastatic or Locally Advanced Epithelioid Sarcoma
Read More
FDA Approvals, In the News
Mixed Findings in Annual Cancer Statistics Report
Read More
FDA Approvals, In the News
FDA Grants Approval to Avapritinib for Patients with GIST
Read More
Perspectives
Paying Tribute to Geno J. Merli, MD, MACP
David B. Nash, MD, MBA
Read More
FDA Approvals, In the News
Recap of FDA Drug Approvals in 2019
Read More
Original Research
Real-World Dose Modification Patterns of Subcutaneous Tocilizumab Among Patients with Rheumatoid Arthritis
Rajeshwari Punekar, MPH, PhD; Jeannie Choi, PharmD; Susan Boklage, MS, MPH; Melitza Iglesias-Rodriguez, MD; Kamala Nola, PharmD, MS
Read More
Perspectives, Business
The Business Case for Social Determinants
David B. Nash, MD, MBA
Read More
Original Research, Practice Management
Outcomes-Based Contracting for Disease-Modifying Therapies in Multiple Sclerosis: Necessary Conditions for Paradigm Adoption
Cori Gray, PharmD; James T. Kenney, RPh, MBA
Stakeholder Perspective
Outcomes-Based Contracts Gaining Traction: Innovative Therapies Will Require Innovative Payment Methods
Gary Branning, MBA
Read More
Pancreatic Cancer, Oncology
A Review of Recent Real-World Evidence Data in Metastatic Pancreatic Cancer
Read More
In the News, Pediatric Cancer, Oncology
FDA Will Require Early Assessment of New Targeted Agents That May Be Used in Pediatric Cancers
Read More
Page 41 of 244
Results 401 - 410 of 2434